Blog

• 
• 
• 
• 

Autism Spectrum Disorder Innovations at Vanderbilt

Deerfield Management and Vanderbilt University announce the launch of Ancora Innovation

Boehringer Ingelheim & Vanderbilt University expand partnership to develop novel treatment approaches for cancer

Vanderbilt researcher uses virtual reality to fight opioid addiction

Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center.

The first two drugs in the new class, alirocumab and evolocumab, were approved by the Food and Drug Administration in 2015. They’re taken by patients who don’t respond well to first-line therapy.

Berries really do pack extra punch – increasing the voltage of spinach-derived biohybrid solar cells developed by Vanderbilt researchers by up to a factor of 20.

The interdisciplinary team discovered that combining a natural dye from blackberries with photosynthetic proteins extracted from spinach leaves creates a device that can produce vastly more voltage than a solar cell made from spinach protein alone.

About one third of patients treated for epilepsy continue to have seizures. Cannabidiol (CBD), one of the many active compounds in the cannabis (marijuana) plant, has gained attention as a treatment for epilepsy. Purified CBD is being tested, but artisanal formulations of CBD (oils) are already available and being used by patients.

Five New Vanderbilt Technologies earn Patent Protection
in February

A team of researchers, led by David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has made a breakthrough discovery in the field of glaucoma showing new hopes for treatments to preserve vision.